Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP583315.RAHvEd4CZZ5EHasqRkG1Yn8E1bcrjkrJw8TGAKJDJQX9c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP583315.RAHvEd4CZZ5EHasqRkG1Yn8E1bcrjkrJw8TGAKJDJQX9c130_assertion type Assertion NP583315.RAHvEd4CZZ5EHasqRkG1Yn8E1bcrjkrJw8TGAKJDJQX9c130_head.
- NP583315.RAHvEd4CZZ5EHasqRkG1Yn8E1bcrjkrJw8TGAKJDJQX9c130_assertion description "[Favorable neuroblastoma genes (EPHB6, EFNB2, EFNB3, NTRK1, and CD44) are genes whose high-level expression predicts favorable neuroblastoma disease outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP583315.RAHvEd4CZZ5EHasqRkG1Yn8E1bcrjkrJw8TGAKJDJQX9c130_provenance.
- NP583315.RAHvEd4CZZ5EHasqRkG1Yn8E1bcrjkrJw8TGAKJDJQX9c130_assertion evidence source_evidence_literature NP583315.RAHvEd4CZZ5EHasqRkG1Yn8E1bcrjkrJw8TGAKJDJQX9c130_provenance.
- NP583315.RAHvEd4CZZ5EHasqRkG1Yn8E1bcrjkrJw8TGAKJDJQX9c130_assertion SIO_000772 17947461 NP583315.RAHvEd4CZZ5EHasqRkG1Yn8E1bcrjkrJw8TGAKJDJQX9c130_provenance.
- NP583315.RAHvEd4CZZ5EHasqRkG1Yn8E1bcrjkrJw8TGAKJDJQX9c130_assertion wasDerivedFrom befree-20140225 NP583315.RAHvEd4CZZ5EHasqRkG1Yn8E1bcrjkrJw8TGAKJDJQX9c130_provenance.
- NP583315.RAHvEd4CZZ5EHasqRkG1Yn8E1bcrjkrJw8TGAKJDJQX9c130_assertion wasGeneratedBy ECO_0000203 NP583315.RAHvEd4CZZ5EHasqRkG1Yn8E1bcrjkrJw8TGAKJDJQX9c130_provenance.